Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 33 Records) |
Query Trace: Rectal Neoplasms and EGFR[original query] |
---|
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009 Mar 20 (3): 469-74. Bengala C, Bettelli S, Bertolini F, Salvi S, Chiara S, Sonaglio C, Losi L, Bigiani N, Sartori G, Dealis C, Malavasi N, D'Amico R, Luppi G, Gatteschi B, Maiorana A, Conte P |
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. British journal of cancer 2010 Sep 103 (7): 1019-24. Bengala C, Bettelli S, Bertolini F, Sartori G, Fontana A, Malavasi N, Depenni R, Zironi S, Del Giovane C, Luppi G, Conte P |
Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response. Pharmacogenomics 2010 Jun 11 (6): 747-61. Balboa Emilia, Duran Goretti, Lamas Maria Jesus, Gomez-Caamaño Antonio, Celeiro-Muñoz Catuxa, Lopez Rafael, Carracedo Angel, Barros Francis |
X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients. International journal of radiation oncology, biology, physics 2012 Jan 82 (1): 138-44. Lamas Maria J, Duran Goretti, Gomez Antonio, Balboa Emilia, Anido Urbano, Bernardez Beatriz, Rana-Diez Pablo, Lopez Rafael, Carracedo Angel, Barros Francis |
Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2011 May 17 (10): 3469-77. Grimminger Peter P, Danenberg Peter, Dellas Kathrin, Arnold Dirk, Rödel Claus, Machiels Jean-Pascal, Haustermans Karin, Debucquoy Annelies, Velenik Vaneja, Sempoux Christine, Bracko Matej, Hölscher Arnulf H, Semrau Robert, Yang Dongyun, Danenberg Kathleen, Lenz Heinz-Josef, Vallböhmer Dani |
Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer. International journal of molecular epidemiology and genetics 2011 2 (4): 4. Poole EM, Curtin K, Hsu L, Kulmacz RJ, Duggan DJ, Makar KW, Xiao L, Carlson CS, Slattery ML, Caan BJ, Potter JD, Ulrich CM |
KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: a pooled analysis of 2 phase II trials. International journal of radiation oncology, biology, physics 2013 Jan 85 (1): 201-7. Kim Sun Young, Shim Eun Kyung, Yeo Hyun Yang, Baek Ji Yeon, Hong Yong Sang, Kim Dae Yong, Kim Tae Won, Kim Jee Hyun, Im Seock-Ah, Jung Kyung Hae, Chang Hee J |
Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Mar 24 (3): 718-25. Helbling D, Bodoky G, Gautschi O, Sun H, Bosman F, Gloor B, Burkhard R, Winterhalder R, Madlung A, Rauch D, Saletti P, Widmer L, Borner M, Baertschi D, Yan P, Benhattar J, Leibundgut E O, Bougel S, Koeberle |
Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy. Annals of surgical oncology 2013 Dec 20 Suppl 3 S599-606. Lai Ching-Yu, Sung Fung-Chang, Hsieh Ling-Ling, Tang Reiping, Chiou Hung-Yi, Wu Fang-Yang, Yeh Chih-Chi |
Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy. Cancers 2013 11 3 (2): 2176-94. Spolverato Gaya, Pucciarelli Salvatore, Bertorelle Roberta, De Rossi Anita, Nitti Dona |
EGFR ligands and DNA repair genes: genomic predictors of complete response after capecitabine-based chemoradiotherapy in locally advanced rectal cancer. The pharmacogenomics journal 2015 Feb 15 (1): 77-83. Sebio A, Salazar J, Páez D, Berenguer-Llergo A, Del Río E, Tobeña M, Martín-Richard M, Sullivan I, Targarona E, Balart J, Baiget M, Barnadas |
The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot study. Annals of surgical oncology 2014 Aug 21 (8): 2642-9. Abdul-Jalil Khairun I, Sheehan Katherine M, Toomey Sinead, Schmid Jasmin, Prehn Jochen, O'Grady Anthony, Cummins Robert, O'Neill Brian, McNamara Deborah A, Deasy Joseph, Breathnach Oscar, Grogan Liam, Rogers Ailin, Doherty Glen, Winter Des, Ryan John, El-Masry Sherif, Gibbons David, Sheahan Kieran, Gillen Peter, Kay Elaine W, Hennessy Bryan |
RAS mutations and cetuximab in locally advanced rectal cancer: results of the EXPERT-C trial. European journal of cancer (Oxford, England : 1990) 2014 May 50 (8): 1430-6. Sclafani F, Gonzalez D, Cunningham D, Hulkki Wilson S, Peckitt C, Giralt J, Glimelius B, Roselló Keränen S, Wotherspoon A, Brown G, Tait D, Oates J, Chau |
KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 20 (1): 128-35. Siyar Ekinci Ahmet, Demirci Umut, Cakmak Oksuzoglu Berna, Ozturk Ayse, Esbah Onur, Ozatli Tahsin, Celik Burcin, Budakoglu Burcin, Turker Ibrahim, Bal Oznur, Turan Ned |
Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Apr 21 (7): 1583-90. Bohanes Pierre, Rankin Cathryn J, Blanke Charles D, Winder Thomas, Ulrich Cornelia M, Smalley Stephen R, Rich Tyvin A, Martensen James A, Benson Al B, Mayer Robert J, Cripps Christine M, Danenberg Kathleen, Makar Karen W, Zhang Wu, Benedetti Jacqueline K, Lenz Heinz-Jos |
(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status. The British journal of radiology 2016 May 20160212. Lovinfosse Pierre, Koopmansch Benjamin, Lambert Frederic, Jodogne Sébastien, Kustermans Gaelle, Hatt Mathieu, Visvikis Dimitris, Seidel Laurence, Polus Marc, Albert Adelin, Delvenne Philippe, Hustinx Rola |
Multiple Gene-Environment Interactions on the Angiogenesis Gene-Pathway Impact Rectal Cancer Risk and Survival. International journal of environmental research and public health 2017 Sep 14 (10): . Sharafeldin Noha, Slattery Martha L, Liu Qi, Franco-Villalobos Conrado, Caan Bette J, Potter John D, Yasui Yuta |
Predictive clinical model of tumor response after chemoradiation in rectal cancer. Oncotarget 2017 Aug 8 (35): 58133-58151. Santos Marisa D, Silva Cristina, Rocha Anabela, Nogueira Carlos, Castro-Poças Fernando, Araujo António, Matos Eduarda, Pereira Carina, Medeiros Rui, Lopes Carl |
Risk factors for brain metastases in patients with metastatic colorectal cancer. Acta oncologica (Stockholm, Sweden) 2017 May 56 (5): 639-645. Christensen Troels Dreier, Palshof Jesper Andreas, Larsen Finn Ole, Høgdall Estrid, Poulsen Tim Svenstrup, Pfeiffer Per, Jensen Benny Vittrup, Yilmaz Mette Karen, Christensen Ib Jarle, Nielsen Dor |
[A Case of Metastatic Colon Cancer Dramatically Affected by Anti-EGFR Antibody Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy 2016 Nov 43 (12): 1800-1802. Yagi Ryoma, Shimada Yoshifumi, Miura Kohei, Tajima Yosuke, Okamura Takuma, Nakano Masato, Ichikawa Hiroshi, Nagahashi Masayuki, Sakata Jun, Kobayashi Takashi, Kameyama Hitoshi, Wakai Toshifumi, Nogami Hitoshi, Maruyama Satoshi, Takii Yasuma |
Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2018 Aug . Wojas-Krawczyk Kamila, Kalinka-Warzocha Ewa, Reszka Katarzyna, Nico? Marcin, Szumi?o Justyna, Ma?dziuk S?awomir, Szczepaniak Katarzyna, Kupnicka Dorota, Lewandowski Remigiusz, Milanowski Janusz, Krawczyk Paw |
Mutation Spectrum of Cancer-Associated Genes in Patients With Early Onset of Colorectal Cancer. Frontiers in oncology 2019 8 9 673. Zhunussova Gulnur, Afonin Georgiy, Abdikerim Saltanat, Jumanov Abai, Perfilyeva Anastassiya, Kaidarova Dilyara, Djansugurova Ley |
Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients. Scientific reports 2019 Nov 9 (1): 16894. Dong Zhouhuan, Kong Linghong, Wan Zhiyi, Zhu Fengwei, Zhong Mei, Lv Yali, Zhao Po, Shi Huaiy |
KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer. PloS one 2020 10 15 (10): e0239806. Jo Peter, Bernhardt Markus, Nietert Manuel, König Alexander, Azizian Azadeh, Schirmer Markus A, Grade Marian, Kitz Julia, Reuter-Jessen Kirsten, Ghadimi Michael, Ströbel Philipp, Schildhaus Hans-Ulrich, Gaedcke Joch |
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon. British journal of cancer 2021 6 125 (6): 816-825. Lee Kun-Han, Chen Wei-Shone, Jiang Jeng-Kai, Yang Shung-Haur, Wang Huann-Sheng, Chang Shih-Ching, Lan Yuan-Tzu, Lin Chun-Chi, Lin Hung-Hsin, Huang Sheng-Chieh, Cheng Hou-Hsuan, Chao Yee, Teng Hao-W |
Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration. Frontiers in immunology 2022 12 13 1013828. Jiang Xiu-Feng, Zhang Bo-Miao, Du Fen-Qi, Guo Jun-Nan, Wang Dan, Li Yi-En, Deng Shen-Hui, Cui Bin-Bin, Liu Yan-Lo |
KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer. International journal of molecular sciences 2023 8 24 (16): . Maria Radanova, Galya Mihaylova, George St Stoyanov, Vyara Draganova, Aleksandar Zlatarov, Nikola Kolev, Eleonora Dimitrova, Nikolay Conev, Diana Ivano |
Response to (K)RAS and EGFR Inhibition in a Patient With NRAS-Mutated Rectal Cancer. JCO precision oncology 2023 6 7 e2200666. Lino Möhrmann, Ani Cuberi, Sascha Brückmann, Sebastian Stasik, Lukas C Heukamp, Martin Bornhäuser, Hanno Glimm, Gunnar Folprec |
Genomic landscape of locally advanced rectal adenocarcinoma: Comparison between before and after neoadjuvant chemoradiation and effects of genetic biomarkers on clinical outcomes and tumor response. Cancer medicine 2023 6 . Tae Hoon Lee, Bum-Sup Jang, Ji Hyun Chang, Eunji Kim, Jeong Hwan Park, Eui Kyu Ch |
Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. British journal of cancer 2024 8 . C Bengala, S Bettelli, F Bertolini, G Sartori, A Fontana, N Malavasi, R Depenni, S Zironi, C Del Giovane, G Luppi, P F Con |
- Page last reviewed:Feb 1, 2024
- Content source: